Novo Nordisk Pharmatech lands record profits in 2020

Novo Nordisk-owned company Novo Nordisk Pharmatech landed record profits in 2020. The firm's soon-to-be-former managing director reasons that this owes to solid advances in two product groups in particular.

Novo Nordisk Pharmatech Managing Director Rasmus Hother le Fevre | Photo: Gregers Tycho/ERH

Novo Nordisk' supply-focused subsidiary Novo Nordisk Pharmatech came out of 2020 with a record profit, according to the 2020 annual financial report for the latter.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs